Media Summary: Cologuard® is a noninvasive, multi-target Patients with inflammatory bowel disease (IBD) are at an increased risk of Dr. John Kisiel explains what you should do if you have a positive result from a

Dna Stool Test For Colon Cancer Mayo Clinic - Detailed Analysis & Overview

Cologuard® is a noninvasive, multi-target Patients with inflammatory bowel disease (IBD) are at an increased risk of Dr. John Kisiel explains what you should do if you have a positive result from a Drs. Victoria Gomez and Michael Wallace, gastroenterologists, share more about Jonathan Ashman, M.D., a radiation oncologist at Paul J. Limburg, M.D. Gastroenterologist at

Webinar was recorded on March 25th , 2015. A variety of

Photo Gallery

DNA Stool Test for Colon Cancer-Mayo Clinic
Mayo Clinic Examines Easier Test for Colon Cancer
Gene Targets Identified for New Non-invasive Colorectal Cancer Screening Test
Mayo Clinic Innovation in Action:  Non-invasive test that can detect early colorectal cancer
Detection of Colorectal Precancerous Lesions in Inflammatory Bowel Disease
Can Stool DNA Test Detect Cancer in IBD Patients?
What if I had a positive colorectal cancer screening test? - Dr. John Kisiel
Mayo Clinic Study Suggests Improved DNA Stool Test Could Detect Digestive Cancers in Multiple Organs
Dr. Dorin T. Colibaseanu - Colorectal Cancer - Mayo Clinic
Minimally Invasive Surgery for Colon and Rectal Cancer - Mayo Clinic
What is the best screening test for colorectal cancer? - Dr. John Kisiel
Colon Cancer Awareness: Dr. Gomez & Dr. Wallace
Sponsored
Sponsored
View Detailed Profile
Sponsored
Sponsored